Next-Generation Sequencing in Oncology

Next-generation sequencing (NGS) has become a cornerstone in oncology research, offering unprecedented insights into the molecular architecture of cancers. This advanced technology allows for a detailed examination of the genetic mutations, variations, and alterations that drive tumor growth. By sequencing the DNA or RNA of cancerous tissues, clinicians can identify specific mutations, enabling personalized treatment options tailored to the individual’s genetic makeup. NGS is also valuable in detecting rare genetic mutations that may not be visible with conventional methods, allowing for early diagnosis and more targeted therapies. As a result, it plays a crucial role in precision medicine, offering hope for more effective treatments and improved patient outcomes.